ProfileGDS4516 / 228425_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 84% 59% 79% 48% 42% 90% 46% 43% 84% 45% 85% 89% 45% 76% 84% 50% 53% 78% 47% 49% 80% 43% 93% 83% 53% 51% 53% 87% 86% 90% 72% 76% 85% 88% 49% 49% 46% 75% 77% 38% 42% 60% 93% 61% 87% 85% 48% 83% 84% 37% 46% 48% 92% 88% 45% 49% 87% 84% 81% 89% 43% 48% 53% 52% 47% 93% 46% 48% 66% 85% 42% 85% 91% 82% 91% 44% 80% 55% 76% 87% 90% 93% 89% 73% 79% 41% 42% 78% 50% 94% 82% 52% 95% 97% 45% 43% 83% 44% 51% 94% 47% 90% 90% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]8.4075984
GSM537345patient 119, cancer, LCM [OPG study]5.9802859
GSM537355patient 138, cancer, LCM [OPG study]7.7482879
GSM537366patient 154, cancer, LCM [OPG study]5.2647148
GSM537370patient 022, cancer, LCM [OPG study]4.9264342
GSM537380patient 037, cancer, LCM [OPG study]9.5716690
GSM537392patient 077, cancer, LCM [OPG study]5.1534946
GSM537415patient 032, cancer, LCM [OPG study]4.9691943
GSM537417patient 042, cancer, LCM [OPG study]8.3209784
GSM537422patient 059, cancer, LCM [OPG study]5.1571945
GSM537423patient 064, cancer, LCM [OPG study]8.5428285
GSM537427patient 084, cancer, LCM [OPG study]9.3491989
GSM537430patient 090, cancer, LCM [OPG study]5.1208445
GSM537336patient 107, cancer, LCM [OPG study]7.4785376
GSM537337patient 108, cancer, LCM [OPG study]8.5099484
GSM537348patient 124, cancer, LCM [OPG study]5.4369550
GSM537349patient 125, cancer, LCM [OPG study]5.5801553
GSM537356patient 139, cancer, LCM [OPG study]7.6849678
GSM537361patient 147, cancer, LCM [OPG study]5.2599847
GSM537374patient 026, cancer, LCM [OPG study]5.3887249
GSM537377patient 033, cancer, LCM [OPG study]7.8191880
GSM537378patient 034, cancer, LCM [OPG study]4.9524943
GSM537379patient 036, cancer, LCM [OPG study]9.840293
GSM537383patient 046, cancer, LCM [OPG study]8.3331783
GSM537388patient 063, cancer, LCM [OPG study]5.6145153
GSM537395patient 082, cancer, LCM [OPG study]5.4263851
GSM537400patient 099, cancer, LCM [OPG study]5.604353
GSM537404patient 129, cancer, LCM [OPG study]8.6214487
GSM537409patient 141, cancer, LCM [OPG study]8.7580186
GSM537418patient 044, cancer, LCM [OPG study]9.5065290
GSM537425patient 070, cancer, LCM [OPG study]7.0492872
GSM537333patient 102, cancer, LCM [OPG study]7.4277176
GSM537342patient 116, cancer, LCM [OPG study]8.6246185
GSM537347patient 123, cancer, LCM [OPG study]8.9808188
GSM537350patient 127, cancer, LCM [OPG study]5.4351949
GSM537362patient 148, cancer, LCM [OPG study]5.3455949
GSM537363patient 150, cancer, LCM [OPG study]5.1860846
GSM537368patient 156, cancer, LCM [OPG study]7.3732775
GSM537376patient 031, cancer, LCM [OPG study]7.4923177
GSM537381patient 038, cancer, LCM [OPG study]4.7310738
GSM537386patient 057, cancer, LCM [OPG study]4.9642742
GSM537398patient 094, cancer, LCM [OPG study]6.0587560
GSM537402patient 109, cancer, LCM [OPG study]10.008693
GSM537405patient 130, cancer, LCM [OPG study]6.1391661
GSM537371patient 023, cancer, LCM [OPG study]9.0024487
GSM537421patient 055, cancer, LCM [OPG study]8.5850485
GSM537424patient 065, cancer, LCM [OPG study]5.3081248
GSM537432patient 097, cancer, LCM [OPG study]8.2452783
GSM537331patient 100, cancer, LCM [OPG study]8.4229984
GSM537332patient 101, cancer, LCM [OPG study]4.6543437
GSM537334patient 103, cancer, LCM [OPG study]5.1849846
GSM537338patient 110, cancer, LCM [OPG study]5.2823748
GSM537353patient 135, cancer, LCM [OPG study]9.8694392
GSM537357patient 142, cancer, LCM [OPG study]9.0696288
GSM537358patient 143, cancer, LCM [OPG study]5.1384845
GSM537375patient 030, cancer, LCM [OPG study]5.3706749
GSM537389patient 068, cancer, LCM [OPG study]9.1268787
GSM537390patient 072, cancer, LCM [OPG study]8.4524184
GSM537393patient 078, cancer, LCM [OPG study]8.1929581
GSM537399patient 095, cancer, LCM [OPG study]8.9883589
GSM537407patient 133, cancer, LCM [OPG study]5.0480143
GSM537408patient 140, cancer, LCM [OPG study]5.2773648
GSM537428patient 086, cancer, LCM [OPG study]5.6582653
GSM537354patient 136, cancer, LCM [OPG study]5.5401252
GSM537410patient 146, cancer, LCM [OPG study]5.250947
GSM537413patient 027, cancer, LCM [OPG study]10.173693
GSM537396patient 083, cancer, LCM [OPG study]5.187246
GSM537397patient 088, cancer, LCM [OPG study]5.2901448
GSM537330patient 006, cancer, LCM [OPG study]6.5494666
GSM537369patient 015, cancer, LCM [OPG study]8.6893385
GSM537373patient 025, cancer, LCM [OPG study]4.943542
GSM537401patient 106, cancer, LCM [OPG study]8.5589685
GSM537343patient 117, cancer, LCM [OPG study]9.6001691
GSM537367patient 155, cancer, LCM [OPG study]8.1281982
GSM537382patient 041, cancer, LCM [OPG study]9.5122691
GSM537385patient 053, cancer, LCM [OPG study]5.0872444
GSM537391patient 073, cancer, LCM [OPG study]7.9171180
GSM537419patient 045, cancer, LCM [OPG study]5.7962255
GSM537420patient 052, cancer, LCM [OPG study]7.3750976
GSM537429patient 089, cancer, LCM [OPG study]8.958587
GSM537431patient 096, cancer, LCM [OPG study]9.0250990
GSM537387patient 061, cancer, LCM [OPG study]10.162393
GSM537414patient 028, cancer, LCM [OPG study]9.27889
GSM537433patient 098, cancer, LCM [OPG study]7.1294173
GSM537335patient 104, cancer, LCM [OPG study]7.9097779
GSM537339patient 111, cancer, LCM [OPG study]4.8371941
GSM537340patient 113, cancer, LCM [OPG study]4.9708342
GSM537344patient 118, cancer, LCM [OPG study]7.6538278
GSM537346patient 011, cancer, LCM [OPG study]5.4077750
GSM537351patient 128, cancer, LCM [OPG study]9.8944294
GSM537352patient 134, cancer, LCM [OPG study]8.1764682
GSM537359patient 144, cancer, LCM [OPG study]5.5913352
GSM537360patient 145, cancer, LCM [OPG study]10.370695
GSM537364patient 152, cancer, LCM [OPG study]11.258297
GSM537365patient 153, cancer, LCM [OPG study]5.1066345
GSM537372patient 024, cancer, LCM [OPG study]5.0486243
GSM537384patient 048, cancer, LCM [OPG study]8.3365183
GSM537394patient 081, cancer, LCM [OPG study]5.0589344
GSM537403patient 121, cancer, LCM [OPG study]5.5203451
GSM537406patient 131, cancer, LCM [OPG study]9.940894
GSM537411patient 149, cancer, LCM [OPG study]5.2833847
GSM537412patient 019, cancer, LCM [OPG study]9.2807890
GSM537416patient 035, cancer, LCM [OPG study]9.5287990
GSM537426patient 079, cancer, LCM [OPG study]8.6681485